Luye Pharma Group Ltd

02186

Company Profile

  • Business description

    Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on development, production, marketing and sale of pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company’s highest revenue share comes from oncology drugs, followed by central nervous system drugs. The company develops drugs for world-wide use in Asia, Europe, and the United States. The Group organizes its business segments by type of products. Oncology drugs, Cardiovascular system drugs, Alimentary tract and metabolism drugs, Central nervous system drugs and others. It derives maximum revenue from the sale of Oncology drugs.

  • Contact

    Hongqiao Road 1438
    22/F, Gubei International Fortune Center II
    Changning District
    Shanghai264003
    CHN

    T: +86 2162376350

    https://www.luye.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    5,150

Stocks News & Analysis

stocks

How to focus on the right things this reporting season

For individual investors, it is important to frame earnings season revelations in a long-term way.
stocks

ASX listed share still a bargain

Shares soared 30% in the last week but are still undervalued.
stocks

Outlook for Nvidia and AMD under Trump’s chip plan

In exchange for an export license to China the chip makers will pay the US government 15% of revenue.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,117.6041.000.45%
CAC 407,698.5244.48-0.57%
DAX 4024,081.3481.52-0.34%
Dow JONES (US)43,975.09200.52-0.45%
FTSE 1009,129.7133.980.37%
HKSE24,906.8147.990.19%
NASDAQ21,385.4064.62-0.30%
Nikkei 22541,820.48761.331.85%
NZX 50 Index12,903.148.72-0.07%
S&P 5006,373.4516.00-0.25%
S&P/ASX 2008,844.8037.700.43%
SSE Composite Index3,647.5512.420.34%

Market Movers